Table 2 Clinical information and demographics of the 56 patients included in the study
Characteristics | pCR | n-pCR | P-value | ||
|---|---|---|---|---|---|
No | % | No | % | ||
Age (years) | 0.585 | ||||
> 50 | 10 | 17.9 | 13 | 23.2 | |
≤50 | 18 | 32.1 | 15 | 26.8 | |
sex | 0.851 | ||||
Male | 16 | 28.6 | 17 | 30.4 | |
female | 12 | 21.4 | 11 | 19.6 | |
Node metastasis | 0.412 | ||||
No | 13 | 23.2 | 9 | 16.1 | |
N1–2 | 15 | 26.8 | 19 | 33.9 | |
Clinical stage | 0.296 | ||||
II- IIIA | 25 | 44.6 | 21 | 37.5 | |
IIIB- IV | 3 | 5.4 | 7 | 12.5 | |
Status | 0.043* | ||||
Survival | 13 | 19.6 | 5 | 8.9 | |
Death | 15 | 30.4 | 23 | 41.1 | |